99 related articles for article (PubMed ID: 1788810)
1. [The characteristics of the postsplenectomy hyperthrombocytic syndrome in patients with chronic myeloleukemia].
Berliner TB; Miasnikov AA; Kheĭfets LM; Polezhaev IuN
Ter Arkh; 1991; 63(7):56-8. PubMed ID: 1788810
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic plateletpheresis in a case of symptomatic thrombocytosis in chronic myeloid leukemia.
Thakral B; Saluja K; Malhotra P; Sharma RR; Marwaha N; Varma S
Ther Apher Dial; 2004 Dec; 8(6):497-9. PubMed ID: 15663550
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of platelet function in postsplenectomy thrombocytosis.
Randi ML; Fabris F; Donà S; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(2):252-6. PubMed ID: 2440781
[TBL] [Abstract][Full Text] [Related]
4. [Chronic myelogenous leukemia with marked thrombocytosis].
Hasegawa T; Hino M; Yamane T; Ota K; Takubo T; Kitagawa S; Tatsumi N
Rinsho Ketsueki; 2001 Mar; 42(3):199-203. PubMed ID: 11345782
[TBL] [Abstract][Full Text] [Related]
5. Early splenectomy in chronic myelogenous leukemia: surgical aspects.
Rodigas P; Conroy J; Pavlides C; Matsumoto T
Am Surg; 1981 May; 47(5):219-23. PubMed ID: 6940464
[TBL] [Abstract][Full Text] [Related]
6. [The prognostic factors in chronic myeloleukemia].
Khoroshko ND
Ter Arkh; 1993; 65(7):23-8. PubMed ID: 8211773
[TBL] [Abstract][Full Text] [Related]
7. [Thrombocytosis in chronic myelogenous leukemia (CML) controlled by interferon alpha (IFN-alpha)].
Koike G; Otsuka T; Shibuya T; Niho Y
Rinsho Ketsueki; 1989 Mar; 30(3):400-3. PubMed ID: 2769964
[TBL] [Abstract][Full Text] [Related]
8. [Benefits of splenectomy in the treatment of chronic leukemia].
Benito Ruiz J; Carbonell Tatay F; del Pino Porres J; Herrero Bernabeu C; Baquero Valdelomar R
Rev Clin Esp; 1990 Feb; 186(3):108-11. PubMed ID: 2356348
[TBL] [Abstract][Full Text] [Related]
9. [Thrombocytosis after splenectomy in children].
Alekseev VS; Platonov AA; Malov AG; Alekseev SV
Vestn Khir Im I I Grek; 2008; 167(4):53-5. PubMed ID: 18942438
[TBL] [Abstract][Full Text] [Related]
10. [Effect of patients' gender on the course of chronic myeloid leukemia].
Abdulkadyrov KM; Rukavitzyn OA; Bessmel'tsev SS; Lomtev AIu
Vopr Onkol; 1997; 43(3):290-4. PubMed ID: 9245084
[TBL] [Abstract][Full Text] [Related]
11. Characteristic changes in platelet-large cell ratio, lactate dehydrogenase and C-reactive protein in thrombocytosis-related diseases.
Kabutomori O; Kanakura Y; Iwatani Y
Acta Haematol; 2007; 118(2):84-7. PubMed ID: 17622783
[TBL] [Abstract][Full Text] [Related]
12. Palliative goals, patient selection, and perioperative platelet management: outcomes and lessons from 3 decades of splenectomy for myelofibrosis with myeloid metaplasia at the Mayo Clinic.
Mesa RA; Nagorney DS; Schwager S; Allred J; Tefferi A
Cancer; 2006 Jul; 107(2):361-70. PubMed ID: 16770787
[TBL] [Abstract][Full Text] [Related]
13. [The diagnosis of a hemorrhagic syndrome in chronic myeloleukemia].
Sakhibov IaD; Sagdieva NSh; Shneĭvaĭs VB; Kalmykova IB
Ter Arkh; 1995; 67(7):26-30. PubMed ID: 7482299
[TBL] [Abstract][Full Text] [Related]
14. [High, asymptomatic and persistent thrombocytosis in splenectomized subjects].
Danilo P; Adriano M; Loredana P
Ann Osp Maria Vittoria Torino; 1977; 20(7-12):169-86. PubMed ID: 757121
[TBL] [Abstract][Full Text] [Related]
15. Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia.
Mesa RA; Elliott MA; Tefferi A
Blood Rev; 2000 Sep; 14(3):121-9. PubMed ID: 10986148
[TBL] [Abstract][Full Text] [Related]
16. [Chronic myelogenous leukemia with marked thrombocytosis--comparison with essential thrombocythemia with Ph1 in its megakaryokinetics].
Kojima H; Hasegawa Y; Ikegami T; Nagasawa T; Abe T
Rinsho Ketsueki; 1990 Jan; 31(1):35-40. PubMed ID: 2313904
[TBL] [Abstract][Full Text] [Related]
17. Budd-Chiari syndrome in chronic myeloid leukemia.
Picardi M; Muretto P; Luciano L
Haematologica; 2000 Apr; 85(4):429. PubMed ID: 10756371
[No Abstract] [Full Text] [Related]
18. Portal, mesenteric, and splenic vein thromboses after splenectomy in a patient with chronic myeloid leukemia variant with thrombocythemic onset.
Lee JJ; Kim HJ; Chung IJ; Park MR; Seo KS; Jeong YY; Kim JK
Am J Hematol; 1999 Jul; 61(3):212-5. PubMed ID: 10398316
[TBL] [Abstract][Full Text] [Related]
19. Immune-mediated complications during interferon alpha therapy in chronic myelogenous leukemia.
Tóthová E; Kafková A; Stecová N; Fricová M; Guman T; Svorcová E
Neoplasma; 2002; 49(2):91-4. PubMed ID: 12088112
[TBL] [Abstract][Full Text] [Related]
20. Prospective study of the incidence and risk factors of postsplenectomy thrombosis of the portal, mesenteric, and splenic veins.
Stamou KM; Toutouzas KG; Kekis PB; Nakos S; Gafou A; Manouras A; Krespis E; Katsaragakis S; Bramis J
Arch Surg; 2006 Jul; 141(7):663-9. PubMed ID: 16847237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
